Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Brain monoamine partial agonists/antagonists claimed by Neurogen

June 28, 1996

DuPont Merck and Richwood enter marketing agreement

June 28, 1996

Fujisawa discloses bradykinin antagonists

June 28, 1996

Asahi Brewery discloses antioxidants

June 21, 1996

Schering AG claims AMPA antagonists for neurodegenerative disorders

June 21, 1996

Hoechst synthesizes NOS inhibitors

June 21, 1996

Approval of Daiichi's Translon imminent

June 21, 1996

Conflicting studies on besipirdine

June 21, 1996

5-HT1A agonist for cognition disorders disclosed

June 21, 1996

Alzheimer's beta-protein inhibition method described

June 21, 1996

Popular Stories

Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for February 3, 2025
Vilastobart set apart? Xilio phase II combo performs in CRC
BioWorld
“The [colorectal cancer field is moving, and thankfully it’s moving quickly,” said Marwan Fakih, gastrointestinal specialist at City of Hope, speaking about...
Novo weight-loss data roll out; Veru ‘leans’ in
BioWorld
As investors look ahead to data shortly from Veru Inc. with enobosarm, the weight-loss space remains hot, with Novo Nordisk A/S reporting favorable top-line...
Appointments and advancements for Jan. 29, 2025
BioWorld
New hires and promotions in the biopharma industry, including: Allogene, Alumis, Beximco, Clarametyx, Commit, Concerto, OS Therapies, Precision, Roche, Scholar Rock.
PFA update: Abbott to launch in EU, J&J hold indefinite
BioWorld MedTech
A pair of investor calls on Jan. 22 added clarity to the rapidly evolving cardiac ablation market with Abbott Laboratories and Johnson & Johnson providing updates...